Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

BCAB

BioAtla Inc

May 13 • 04:00PM ET

4.40

-0.14 -3.08 %

Healthcare • Biotechnology • USA • Nano • NASD

Peers: SABS IMNN BCTX BLRX HOTH

| Held by: VTI VXF BTEC

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-50.76	Insider Own	18.72%	Shs Outstand	1.66M	Perf Week	-2.22%
Market Cap	7.30M	Forward P/E	-	EPS next Y	-	Insider Trans	0.00%	Shs Float	1.38M	Perf Month	3.04%
Enterprise Value	10.52M	PEG	-	EPS next Q	-	Inst Own	10.47%	Short Float	10.67%	Perf Quarter	-52.30%
Income	-59.61M	P/S	3.65	EPS this Y	-	Inst Trans	-0.18%	Short Ratio	3.73	Perf Half Y	-86.22%
Sales	2.00M	P/B	-	EPS next Y	-	ROA	-176.84%	Short Interest	0.15M	Perf YTD	-84.50%
Book/sh	-28.51	P/C	1.03	EPS next 5Y	-	ROE	-813.88%	52W High	71.50 -93.85%	Perf Year	-79.98%
Cash/sh	4.29	P/FCF	-	EPS past 3/5Y	28.18% 0.99%	ROIC	-	52W Low	3.92 12.24%	Perf 3Y	-97.60%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	- 36.06%	Gross Margin	81.35%	Volatility	9.95% 11.59%	Perf 5Y	-99.81%
Dividend TTM	-	EV/Sales	5.26	EPS Y/Y TTM	29.36%	Oper. Margin	-2965.25%	ATR (14)	0.60	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	0.37	Sales Y/Y TTM	-81.82%	Profit Margin	-2980.35%	RSI (14)	41.17	Recom	1.00
Dividend Gr. 3/5Y	- -	Current Ratio	0.37	EPS Q/Q	45.09%	SMA20	-6.64%	Beta	0.80	Target Price	200.00
Payout	-	Debt/Eq	-	Sales Q/Q	-	SMA50	-29.21%	Rel Volume	0.29	Prev Close	4.54
Employees	41	LT Debt/Eq	-	Earnings	Mar 31 AMC	SMA200	-80.39%	Avg Volume	39.47K	Price	4.40
IPO	Dec 16, 2020	Option/Short	No / Yes	EPS/Sales Surpr.	- -	Trades		Volume	11,601	Change	-3.08%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)